Zurzuvae 25 MG Oral Capsule

RxCUI: 2669920
RxNorm name: Zurzuvae 25 MG Oral Capsule
Display name: Zurzuvae 25 MG Oral Capsule
Full name: Zurzuvae 25 MG Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ZURZUVAE	ZURANOLONE	Biogen MA Inc.	f18e53b0-d0bb-422d-8de7-ab64b7292b29	2026-06-15	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2669920

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
f18e53b0-d0bb-422d-8de7-ab64b7292b29	Zurzuvae 25 MG Oral Capsule	SY	17	These highlights do not include all the information needed to use ZURZUVAE safely and effectively. See full prescribing information for ZURZUVAE. ZURZUVAE ® (zuranolone) capsules, for oral use, CIV Initial U.S. Approval: 2023	20260421
f18e53b0-d0bb-422d-8de7-ab64b7292b29	ZURZUVAE 25 MG Oral Capsule	PSN	17	These highlights do not include all the information needed to use ZURZUVAE safely and effectively. See full prescribing information for ZURZUVAE. ZURZUVAE ® (zuranolone) capsules, for oral use, CIV Initial U.S. Approval: 2023	20260421
f18e53b0-d0bb-422d-8de7-ab64b7292b29	zuranolone 25 MG Oral Capsule [Zurzuvae]	SBD	17	These highlights do not include all the information needed to use ZURZUVAE safely and effectively. See full prescribing information for ZURZUVAE. ZURZUVAE ® (zuranolone) capsules, for oral use, CIV Initial U.S. Approval: 2023	20260421